As of the latest SEC filings, Regencell Bioscience Holdings Ltd (RGC) is held by 6 institutional funds. The largest fund shareholder is Fidelity Nasdaq Composite Index Fund (FNCMX), holding an estimated $7,661,573.16 in market value, representing 0.03% of its portfolio.
Funds holding Regencell Bioscience Holdings Ltd (RGC)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- RGC
- CIK:
- 0001829667
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.03% | $7,661,573.16 | 292,092 | Feb 28, 2026 | Apr 24, 2026 |
|
ONEQ
Fidelity Nasdaq Composite Index ETF
|
ETF | Fidelity | 0.03% | $3,113,632.15 | 118,705 | Feb 28, 2026 | Apr 24, 2026 |
|
GXC
State Street(R) SPDR(R) S&P(R) China ETF
|
ETF | State Street (SPDR) | 0.02% | $103,016.93 | 4,051 | Mar 31, 2026 | May 28, 2026 |
|
BKIE
BNY Mellon International Equity ETF
|
ETF | Independent / Boutique | 0.00% | $36,495.78 | 1,249 | Apr 30, 2026 | Jun 26, 2026 |
|
GSID
Goldman Sachs MarketBeta International Equity ETF
|
ETF | Goldman Sachs | 0.00% | $33,836.70 | 1,290 | Feb 28, 2026 | Apr 28, 2026 |
|
EEMO
Invesco S&P Emerging Markets Momentum ETF
|
ETF | Invesco | 0.06% | $7,830.96 | 268 | Apr 30, 2026 | Jun 26, 2026 |
Advertisement (320x50)